Acknowledging the significance of androgen receptor signaling as critical targets in prostate cancer treatment and recognizing the constraints imposed by autophagy on the efficacy of antiandrogen therapy, our study sought to determine whether modulating autophagy could amplify the effectiveness of antiandrogen therapy with Abi in an in vivo mouse model. This evidence concerns the gene AR and prostate carcinoma.